MannKind Corp (MNKD)
4.62
+0.15
(+3.36%)
USD |
NASDAQ |
Mar 18, 16:00
4.66
+0.04
(+0.87%)
After-Hours: 20:00
MannKind Gross Profit Margin (Quarterly): 69.10% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 69.10% |
September 30, 2023 | 72.19% |
June 30, 2023 | 70.71% |
March 31, 2023 | 60.09% |
December 31, 2022 | 55.28% |
September 30, 2022 | 46.81% |
June 30, 2022 | 31.64% |
March 31, 2022 | 8.29% |
December 31, 2021 | 8.64% |
September 30, 2021 | 55.49% |
June 30, 2021 | 57.36% |
March 31, 2021 | 56.35% |
December 31, 2020 | 65.93% |
September 30, 2020 | 66.31% |
June 30, 2020 | 62.55% |
Date | Value |
---|---|
March 31, 2020 | 53.64% |
December 31, 2019 | 56.10% |
September 30, 2019 | 38.78% |
June 30, 2019 | 56.90% |
March 31, 2019 | 68.15% |
December 31, 2018 | 62.18% |
September 30, 2018 | -18.66% |
June 30, 2018 | -30.88% |
March 31, 2018 | -15.67% |
December 31, 2017 | -10.77% |
September 30, 2017 | -123.9% |
June 30, 2017 | -135.1% |
March 31, 2017 | 15.32% |
December 31, 2016 | -16.40% |
September 30, 2016 | 83.29% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
8.29%
Minimum
Mar 2022
72.19%
Maximum
Sep 2023
53.02%
Average
56.63%
Median
Gross Profit Margin (Quarterly) Benchmarks
United Therapeutics Corp | 88.45% |
Corcept Therapeutics Inc | 98.61% |
Cassava Sciences Inc | -- |
Amphastar Pharmaceuticals Inc | 53.98% |
Cogent Biosciences Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Assets | -3.51% |
Return on Invested Capital | -60.02% |
Profit Margin (Quarterly) | 2.40% |
Operating Margin (Quarterly) | 18.19% |
Return on Net Operating Assets | -10.37% |